Renata Gizani de Moura Leite, Anna Paula Mendanha da Silva Aureliano, Sara Cardoso Paes Rose, Luana Dantas Barbosa and Liliana Sampaio Costa Mendes*

Gastroenterology Service, Federal District Base Hospital Institute, Brasília - DF, Brazil

*Corresponding Author: Liliana Sampaio Costa Mendes, Gastroenterology Service, Federal District Base Hospital Institute, Brasília - DF, Brazil.

Received: August 16, 2021; Published: August 30, 2021

Abstract

  Pancreatic ascites (PA) is a rare cause of ascites and usually appears as consequence of chronic pancreatitis. It results from an excess of exudative intraperitoneal fluid, rich in amylase and proteins, commonly originated from a pseudocyst or pancreatic duct disruption. Patients typically present mild abdominal pain, hyporexia, and sense of fullness. The diagnosis is characterized by high levels of amylase (above 1000 U/L), proteins (above 3 g/dl) and low serum ascites albumin gradient - SAAG (< 1.1 g/dl) at the ascitic fluid. The objective of this study is to report a case of a cirrhotic patient with the diagnosis of pancreatic ascites and discuss it laboratory and imaging findings, as well the main causes and treatments for this case. PA is a rare entity and either more, when occur in a cirrhotic patient. The management of cirrhotic ascites is different when there is PA. The clinicians should be aware of this possibility.

Keywords: Ascites; Pancreatic Fistula; Chronic Pancreatitis; Liver Cirrhosis; Chronic Pancreatitis

References

1. Junior DRA., et al. “Ascite: estado da arte baseado em evidências”. Revista da Associacao Medica Brasileira4 (2009): 489-496.
2. Smith EB. “Hemorrhagic ascites and hemothorax associated with benign pancreatic disease”. Archives of Surgery1 (1953): 52-56.
3. Fernández-Cruz L., et al. “Pancreatic ascites”. Hepatogastroenterology2 (1993): 150-154.
4. Bhandari R., et al. “Pancreatic ascites managed with a conservative approach: a case report”. Journal of Medical Case Reports1 (2020): 154.
5. Martins Junior EV., et al. “Pancreatic ascites - case report”. Revista da Sociedade Brasileira de Clínica Médica1 (2003): 26-28.
6. Carrier P., et al. “L'ascite non liée à lacirrhose: physiopathologie, diagnostic et étiologies [Non-cirrhotic ascites: pathophysiology, diagnosisandetiology]”. La Revue de Médecine Interne6 (2014): 365-371.
7. Kanneganti K., et al. “Successful Management of Pancreatic Ascites with both Conservative Management and Pancreatic Duct Stenting”. Gastroenterology Research4 (2009): 245-247.
8. Gómez-Cerezo J., et al. “Pancreatic ascites: study of therapeutic options by analysis of case reports and case series between the years 1975 and 2000”. The American Journal of Gastroenterology3 (2003): 568-577.
9. Parekh D and Segal I. “Pancreatic ascites and effusion. Risk factors for failure of conservative therapy and the role of octreotide”. The Archives of Surgery2 (1992): 707-712.
10. Moosa AR. “Surgical treatment of chronic pancretitis: an overview”. British Journal of Surgery8 (1987): 661-667.
11. Munshi IA., et al. “Resolution of refractory pancreatic ascites after continuous infusion of octreotide acetate”. International Journal of Pancreatology2 (1995): 203-206.

Citation

Citation: Liliana Sampaio Costa Mendes., et al. “Pancreatic Ascites in a Cirrhotic Patient, a Case Report”. Acta Scientific Gastrointestinal Disorders 4.9 (2021): 73-76.

Copyright

Copyright: © 2021 Liliana Sampaio Costa Mendes., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.